Atnaujinkite slapukų nuostatas

Oxford Handbook of Oncology 4th Revised edition [Part-work (fascķculo)]

3.92/5 (15 ratings by Goodreads)
Edited by (University of Glasgow), Edited by (Oxfor), Edited by (Consultant in Clinical Oncology,, Aberdeen Royal Infirmary, Aberdeen, UK), Edited by , Edited by (Consultant Surgeon; Honorary Professor, Belfast Trust; Queen University, Belfast, University of Ulster, Northern Ireland, UK)
  • Formatas: Part-work (fascķculo), 896 pages, aukštis x plotis x storis: 184x105x27 mm, weight: 541 g, 25 black and white line illustrations and 6 colour plates
  • Serija: Oxford Medical Handbooks
  • Išleidimo metai: 13-Aug-2015
  • Leidėjas: Oxford University Press
  • ISBN-10: 0199689849
  • ISBN-13: 9780199689842
Kitos knygos pagal šią temą:
  • Formatas: Part-work (fascķculo), 896 pages, aukštis x plotis x storis: 184x105x27 mm, weight: 541 g, 25 black and white line illustrations and 6 colour plates
  • Serija: Oxford Medical Handbooks
  • Išleidimo metai: 13-Aug-2015
  • Leidėjas: Oxford University Press
  • ISBN-10: 0199689849
  • ISBN-13: 9780199689842
Kitos knygos pagal šią temą:
Now fully revised and in its fourth edition, the Oxford Handbook of Oncologyhas been the essential go-to guide for students and practitioners in oncology for over a decade. The scientific basis and diagnosis of cancers is covered, as well as drugs, biomarkers, and the presentation and psychosocial aspects of oncology. Concise, practical, and comprehensive, there is no better companion for both common conditions and challenging emergencies.

The field of oncology has surged forward since the last edition was published and theOxford Handbook of Oncology has been fully revised and updated to reflect these recent advances so you can be sure that the vital information you need is in your hands. This handbook incorporates changes such as the understanding of the science of cancer, novel therapies in breast, lung, renal, and melanoma, molecular sub-classification of common solid cancers, personalized therapy approaches, new agents in hard to treat cancers, the benefits of new technologies in radiotherapy, and the emerging data on the importance of the immune response.

Written by experts in the field to ensure that it is grounded in real life clinical practice, this handbook provides a concise guide to all aspects of oncology for all students, nurses, and junior faculty responsible for the care of cancer patients, while also providing further reading and highlighting areas of controversy for those who need a more detailed understanding.

Recenzijos

Written by experts in the field to ensure that it is grounded in real life clinical practice, this Handbook provides a concise guide to all aspects of oncology for all students, nurses, and junior faculty responsible for the care of cancer patients, while also providing further reading and highlighting areas of controversy for those who need a more detailed understanding. * Anticancer Research *

Symbols and abbreviations xii
Part 1 Background
1 Aetiology and epidemiology
3(14)
2 The genetics of cancer
17(14)
3 Surgical oncology
31(18)
Part 2 Principles of treatment
4 Principles of radiation oncology
49(34)
5 Principles of chemotherapy
83(28)
6 Principles of symptom control in palliative care
111(46)
7 Late effects of chemotherapy and radiotherapy
157(12)
8 Hormone therapy
169(10)
9 Targeted and biological therapies
179(20)
Part 3 Clinical trials, cancer prevention, and screening
10 Clinical trials
199(4)
11 Cancer prevention
203(14)
12 Population screening for cancer
217(8)
Part 4 Specific types of cancer
13 Thoracic malignancies
225(36)
14 Breast cancer
261(38)
15 Colorectal cancer
299(12)
16 Anal cancer
311(6)
17 Upper gastrointestinal cancer
317(64)
18 Endocrine cancers
381(22)
19 Genitourinary cancers
403(42)
20 Gynaecological cancers
445(22)
21 Head and neck cancers
467(28)
22 Tumours of the central nervous system
495(28)
23 Skin cancers
523(26)
24 Haematological malignancies
549(54)
25 Bone and soft tissue malignancies
603(26)
26 Malignancy of unknown primary
629(16)
27 Paraneoplastic syndromes
645(10)
28 AIDS-related malignancies
655(16)
29 Childhood cancers presenting in adults
671(10)
Part 5 Emergencies in oncology
30 Spinal cord compression and bone marrow suppression
681(10)
31 Overview of acute oncology
691(4)
32 Superior vena cava obstruction and raised intracranial pressure
695(8)
33 Airway obstruction
703(8)
34 Thromboembolic and cardiac emergencies
711(8)
35 Obstruction
719(12)
36 Biochemical crises
731(12)
37 Complications of long-term central venous lines and chemotherapy extravasation
743(6)
Part 6 The way forward
38 Novel therapeutic strategies
749(10)
39 Gene therapy and genetic immunotherapy for cancer
759(14)
40 Biomarkers and cancer
773(12)
Part 7 Appendices
Appendix 1 NCIC common toxicity criteria (CTC) grading system (March 1998, revised)
785(68)
Appendix 2 Nomogram for the determination of body surface area
853(2)
Appendix 3 Performance status
855(2)
Appendix 4 Support agencies' addresses and websites
857(2)
Index 859
Jim Cassidy was previously Professor of Oncology at Aberdeen university (1994-2002), then CRUK Head of Oncology, Beatson Laboratories, Glasgow. He moved into pharma over 2 years ago to head early drug development.

Donald Bissett was schooled in Glasgow, and graduated from St Andrews University 1979 and University of Manchester 1982. Clinical experience in South Manchester Hospitals led to MRCP 1986, then commenced clinical oncology training in Nottingham and Glasgow, with FRCR 1989. Research Fellowship in the Department of Medical Oncology Beatson Institute, with MD and MSc in Clinical Pharmacology 1992. Senior lecturer in Clinical Oncology 1994, then Consultant in Clinical Oncology in Aberdeen 1995-2013 with particular interests in urological and thoracic malignancies.